BeStock  

Royal Philips PHG

US equityMarket cap rank #709Medical DevicesSmart Home
$28.61 −$0.64 (-2.19%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $28.61 0.00%
Open$28.89
Prev close$29.25
Day range$28.56 – $29.14
Volume2.42M
Market cap$27.97B
P/E (TTM)26.3
Dividend yield3.44%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026 · reported in EUR

Revenue€4.39B+2.1% YoY
Operating profit€165.00M-50.0% YoY
Net profit€28.00M-85.0% YoY
Diluted EPS€0.03-84.2% YoY
Free cash flow€382.00M+126.0% YoY
Operating cash flow€544.00M

Revenue, last 8 quarters

€5.0BDec '24€4.1BMar '25€4.3BJun '25€4.3BSep '25€5.1BDec '25€3.9BMar '26€4.4BJun '26€4.4BSep '26

Net profit, last 8 quarters

€-333.0MDec '24€72.0MMar '25€240.0MJun '25€187.0MSep '25€398.0MDec '25€146.0MMar '26€386.0MJun '26€28.0MSep '26

Diluted EPS by quarter

-0.36Dec '240.08Mar '250.25Jun '250.19Sep '250.42Dec '250.16Mar '260.40Jun '260.03Sep '26

Free cash flow by quarter

€1.3BDec '24€-1.1BMar '25€228.0MJun '25€169.0MSep '25€1.2BDec '25€25.0MMar '26€219.0MJun '26€382.0MSep '26

Annual revenue

€17.3BFY20€17.2BFY21€17.8BFY22€18.2BFY23€18.0BFY24€17.8BFY25

Profitability & balance sheet

Gross margin46.4%
Operating margin8.9%
Net margin5.4%
Return on equity8.6%
Return on assets3.5%
Return on invested capital5.7%
Current ratio1.33
Liabilities / assets58.6%
Cash & investments€2.75B
Total debt€8.14B
Net cash (debt)-€5.39B
Free cash flow / sales10.3%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Diagnosis & Treatment€2.09B 47.5%
  • Connected Care€1.18B 26.8%
  • Personal Health€953.00M 21.7%
  • Other€179.00M 4.1%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Revenue as Reported €4.39B €4.36B €3.91B €17.83B €5.10B
Total Operating Revenue €4.39B €4.36B €3.91B €17.83B €5.10B
Cost of Revenue €2.35B €2.21B €2.14B €9.78B €2.81B
Gross Profit €2.04B €2.15B €1.77B €8.06B €2.29B
Operating Expense €1.88B €1.54B €1.52B €6.61B €1.72B
Selling and Admin Expenses €1.17B €1.21B €1.18B €4.97B €1.31B
-Selling & Marketing Expense €1.02B €1.05B €1.01B €4.34B €1.15B
-General & Admin Expense €158.00M €154.00M €177.00M €628.00M €158.00M
Research & Development €410.00M €484.00M €394.00M €1.70B €427.00M
Other Operating Expenses €291.00M -€151.00M -€54.00M -€61.00M -€9.00M
Operating Profit €165.00M €610.00M €242.00M €1.45B €565.00M
Net Non-Operating Interest Income (Expense) -€42.00M -€62.00M -€48.00M -€216.00M -€53.00M
Non-Operating Interest Income €42.00M €33.00M €35.00M €83.00M €8.00M
Non-Operating Interest Expense €84.00M €95.00M €83.00M €294.00M €56.00M
Other Income (Expense) -€1.00M -€1.00M -€4.00M -€50.00M -€44.00M
Earnings from Equity Interest -€1.00M -€1.00M -€4.00M -€9.00M -€3.00M
Pretax Profit €122.00M €546.00M €190.00M €1.18B €466.00M
Tax €92.00M €160.00M €44.00M €282.00M €74.00M
Net Profit €28.00M €386.00M €146.00M €897.00M €398.00M
Profit from Continuing Operations €30.00M €386.00M €146.00M €901.00M €393.00M
Net Income from Discontinuous Operations -€2.00M €0.00 €0.00 -€4.00M €4.00M
Minority Interests €1.00M €2.00M -€5.00M €1.00M €2.00M
Net Income to Parent Company €27.00M €384.00M €151.00M €895.00M €395.00M
Net Income to Common Stockholders €27.00M €384.00M €151.00M €895.00M €395.00M
Basic EPS €0.03 €0.40 €0.16 €0.94 €0.42
Diluted EPS €0.03 €0.40 €0.16 €0.93 €0.42
Dividend Per Share €0.00 €0.87 €0.00 €0.85 €0.00
Total Other Finance Costs – – – €5.00M –
Gain on Sale of Security – – – -€17.00M –
Special Income (Charges) – – – -€24.00M –
-Less:Impairment of Capital Assets – – – €0.00 –
-Gain on Sale Of Business – – – -€25.00M –
-Gain on Sale of Property/Plant/Equipment – – – €1.00M –

Balance sheet

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Assets €28.03B €26.70B €27.27B €26.94B €26.94B
Total Current Assets €10.51B €9.33B €9.78B €9.93B €9.93B
Cash and Cash Equivalents & Short-Term Investments €2.75B €1.79B €2.59B €2.79B €2.79B
-Cash and Cash Equivalents €2.75B €1.79B €2.59B €2.79B €2.79B
Receivables €3.62B €3.60B €3.31B €3.95B €3.95B
-Accounts Receivable €3.57B €3.55B €3.26B €3.34B €3.34B
-Taxes Receivable €49.00M €47.00M €45.00M €60.00M €60.00M
Inventory €3.40B €3.22B €3.11B €2.87B €2.87B
Other Current Assets €686.00M €665.00M €628.00M -€5.00M -€5.00M
Total Non-Current Assets €17.52B €17.37B €17.48B €17.01B €17.01B
Net PPE €2.20B €2.17B €2.18B €2.22B €2.22B
Investments and Advances €876.00M €862.00M €850.00M €852.00M €852.00M
-Long Term Equity Investment €153.00M €151.00M €142.00M €148.00M €148.00M
Non Current Accounts Receivables €211.00M €202.00M €220.00M €210.00M €210.00M
Goodwill and Other Intangible Assets €12.28B €12.24B €12.30B €11.84B €11.84B
-Goodwill €9.74B €9.68B €9.61B €9.27B €9.27B
-Other Intangible Assets €2.54B €2.56B €2.69B €2.57B €2.57B
Non-Current Deferred Assets €1.83B €1.77B €1.81B €1.77B €1.77B
Other Non-Current Assets €121.00M €128.00M €121.00M €119.00M €119.00M
Total Liabilities €16.42B €15.23B €15.85B €15.96B €15.96B
Total Current Liabilities €7.91B €7.42B €7.43B €7.51B €7.51B
Payables €2.39B €2.29B €2.19B €2.25B €2.25B
-Accounts Payable €2.14B €2.08B €1.99B €1.93B €1.93B
-Total Tax Payable €258.00M €168.00M €198.00M €307.00M €307.00M
Current Accrued Expenses €1.50B €1.44B €1.33B €1.74B €1.74B
Short-Term Debt and Capital Lease Obligation €1.15B €1.15B €1.21B €1.00B €1.00B
-Current Debt €1.15B €1.15B €1.21B €793.00M €793.00M
Current Provisions €815.00M €553.00M €602.00M €712.00M €712.00M
Current Deferred Liabilities €1.64B €1.58B €1.62B €1.49B €1.49B
Other Current Liabilities €415.00M €409.00M €494.00M €321.00M €321.00M
Total Non-Current Liabilities €8.51B €7.80B €8.42B €8.44B €8.44B
Long Term Debt and Capital Lease Obligation €6.99B €6.32B €6.89B €6.81B €6.81B
-Long Term Debt €6.99B €6.32B €6.89B €6.05B €6.05B
Non-Current Liabilities €877.00M €865.00M €879.00M €915.00M €915.00M
Non-Current Deferred Liabilities €564.00M €541.00M €529.00M €551.00M €551.00M
Other Non-Current Liabilities €84.00M €80.00M €117.00M €44.00M €44.00M
Total Equity €11.61B €11.48B €11.42B €10.99B €10.99B
Stockholders' Equity €11.58B €11.45B €11.39B €10.96B €10.96B
Capital Stock €197.00M €197.00M €193.00M €193.00M €193.00M
-Common Stock €197.00M €197.00M €193.00M €193.00M €193.00M
Additional Paid-In Capital €7.67B €7.67B €7.21B €7.21B €7.21B
Retained Earnings €3.21B €3.18B €3.71B €3.58B €3.58B
Less: Treasury Stock -€110.00M -€113.00M -€265.00M -€298.00M -€298.00M
Gains/Losses Not Affecting Retained Earnings €707.00M €644.00M €527.00M €291.00M €291.00M
Other Equity Interests -€91.00M -€130.00M €12.00M -€16.00M -€16.00M
Minority Interests €29.00M €29.00M €26.00M €32.00M €32.00M
-Dividends Payable – €37.00M – – –
-Due from Related Parties Current – – – €19.00M €19.00M
-Other Receivables – – – €527.00M €527.00M
Prepaid Assets – – – €180.00M €180.00M
-Gross PPE – – – €5.92B €5.92B
-Accumulated Depreciation – – – -€3.71B -€3.71B
-Available for Sale Securities – – – €324.00M €324.00M
-Other Payable – – – €17.00M €17.00M
-Current Capital Lease Obligation – – – €207.00M €207.00M
-Long Term Capital Lease Obligation – – – €757.00M €757.00M
Derivative Product Liabilities – – – €123.00M €123.00M

Cash flow

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Operating Cash Flow €544.00M €376.00M €188.00M €1.17B €1.39B
Net cash flow from continuing operations €544.00M €377.00M €190.00M €1.17B €1.39B
Net Income from Continuing Operations €30.00M €386.00M €146.00M €901.00M €394.00M
Gain/Loss from Continuing Operations €2.00M -€98.00M €17.00M €32.00M €27.00M
Depreciation & Depletion & Amortization €254.00M €381.00M €265.00M €1.12B €278.00M
Deferred Tax €92.00M €160.00M €44.00M €282.00M €74.00M
Other Non-Cash Items €11.00M €23.00M €8.00M €294.00M €73.00M
Change in Working Capital €220.00M -€329.00M -€263.00M -€1.23B €581.00M
-Change in Receivables -€10.00M -€301.00M €219.00M -€53.00M -€175.00M
-Change in Inventory -€201.00M -€113.00M -€226.00M -€115.00M €355.00M
-Change in Payables and Accrued Expense €148.00M €136.00M -€115.00M €97.00M €360.00M
-Change in Other Current Liabilities €22.00M €19.00M €18.00M €54.00M €50.00M
-Change In Other Working Capital €261.00M -€70.00M -€159.00M -€1.22B -€9.00M
Net cash flow from investing -€150.00M -€19.00M -€406.00M -€737.00M -€196.00M
Net Cash Flow from Continuing Investing Activities -€150.00M -€20.00M -€406.00M -€736.00M -€196.00M
Capital Expenditure -€136.00M -€130.00M -€136.00M -€532.00M -€148.00M
Net PPE Purchase and Sale €2.00M €3.00M €3.00M €9.00M €2.00M
Net Intangibles Purchase and Sale -€26.00M -€27.00M -€27.00M -€136.00M -€44.00M
Net Business Purchase and Sale -€6.00M €121.00M -€221.00M -€25.00M -€18.00M
Net Investment Purchase and Sale €16.00M €13.00M -€25.00M -€52.00M €12.00M
Financing Cash Flow €566.00M -€1.15B -€23.00M €107.00M -€322.00M
Net Cash Flow from Continuing Financing Activities €566.00M -€1.15B -€23.00M €107.00M -€322.00M
Net Issuance Payments Of Debt €603.00M -€767.00M -€34.00M €424.00M -€327.00M
Net Common Stock Issuance €1.00M -€65.00M €12.00M €13.00M €5.00M
Cash Dividends Paid -€37.00M -€321.00M – -€328.00M €0.00
Net Other Financing Charges -€1.00M -€1.00M -€1.00M -€2.00M €0.00
Ending Cash Balance €2.75B €1.79B €2.59B €2.79B €2.79B
Net Change in Cash €959.00M -€797.00M -€241.00M €532.00M €872.00M
Beginning Cash Balance €1.79B €2.59B €2.79B €2.40B €1.91B
Effect of Exchange Rate Changes €3.00M -€6.00M €39.00M -€139.00M €10.00M
Free Cash Flow €382.00M €219.00M €25.00M €504.00M €1.20B
Net Other Investing Changes – €1.00M – -€1.00M €0.00

Discussion

No comments yet — be the first to weigh in on PHG.

Sign in to join the discussion.

Scroll to Top